pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104

The role of pERK, pAKT and p53 as biomarkers in patients with advanced pancreatic cancer has not yet been defined.

Saved in:

Bibliographic Details
Main Authors:	Ormanns, Steffen (Author) , Siveke, Jens T. (Author) , Heinemann, Volker (Author) , Haas, Michael (Author) , Sipos, Bence (Author) , Schlitter, Anna Melissa (Author) , Esposito, Irene (Author) , Jung, Andreas (Author) , Laubender, Rüdiger P. (Author) , Kruger, Stephan (Author) , Vehling-Kaiser, Ursula (Author) , Winkelmann, Cornelia (Author) , Fischer von Weikersthal, Ludwig (Author) , Clemens, Michael R. (Author) , Gauler, Thomas C. (Author) , Märten, Angela (Author) , Geißler, Michael (Author) , Greten, Tim F. (Author) , Kirchner, Thomas (Author) , Boeck, Stefan (Author)
Format:	Article (Journal)
Language:	English
Published:	28 August 2014
In:	BMC cancer Year: 2014, Volume: 14
ISSN:	1471-2407
DOI:	10.1186/1471-2407-14-624
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/1471-2407-14-624 Verlag, lizenzpflichtig, Volltext: https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-14-624
Author Notes:	Steffen Ormanns, Jens T. Siveke, Volker Heinemann, Michael Haas, Bence Sipos, Anna Melissa Schlitter, Irene Esposito, Andreas Jung, Rüdiger P. Laubender, Stephan Kruger, Ursula Vehling-Kaiser, Cornelia Winkelmann, Ludwig Fischer von Weikersthal, Michael R. Clemens, Thomas C. Gauler, Angela Märten, Michael Geissler, Tim F. Greten, Thomas Kirchner and Stefan Boeck

Description
Summary:	The role of pERK, pAKT and p53 as biomarkers in patients with advanced pancreatic cancer has not yet been defined.
Item Description:	Gesehen am 09.09.2020
Physical Description:	Online Resource
ISSN:	1471-2407
DOI:	10.1186/1471-2407-14-624